(Press-News.org) Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.
Results from the Phase III CheckMate 77T study were published today in the New England Journal of Medicine. At a median follow-up of 25.4 months, the median EFS with chemotherapy alone was 18.4 months, while the median had not yet been reached for patients receiving perioperative nivolumab, meaning EFS was prolonged significantly over the control group. These results correspond to a 42% reduction in risk of disease progression, recurrence, or death for those receiving the perioperative combination.
This data was first presented at the 2023 European Society for Medical Oncology (ESMO) Congress.
Patients who received the perioperative nivolumab-based regimen also saw significantly higher rates of pathological complete response (pCR), defined as no tumor remaining at surgery, compared with those who received chemotherapy alone (25.3% vs. 4.7%). Rates of major pathological response (MPR), less than or equal to 10% of viable tumor cells remaining at time of surgery, were also higher in patients who received perioperative immunotherapy (35.4% vs. 12.1%).
“This study builds on the standard-of-care neoadjuvant chemoimmunotherapy treatment and supports perioperative nivolumab as an effective approach that reduces the risk of lung cancer relapse,” said principal investigator Tina Cascone, M.D., Ph.D., associate professor of Thoracic/Head & Neck Medical Oncology. “These findings add to evidence that the perioperative immunotherapy path gives patients with operable lung cancer an opportunity to live longer without their cancer returning.”
Roughly 30% of patients diagnosed with NSCLC have operable disease, meaning their tumor can be removed by a surgical operation. While many of these patients can be potentially cured by surgery, more than half will experience cancer recurrence without additional therapy. Chemotherapy given either before or after surgery provides only a minimal survival benefit.
The randomized, double-blind CheckMate 77T trial, which began in 2019, included more than 450 NSCLC patients over the age of 18 from around the globe. Participants were randomized to treatment with either neoadjuvant nivolumab with chemotherapy followed by surgery and adjuvant nivolumab, or neoadjuvant chemotherapy and placebo followed by surgery and adjuvant placebo
The data showed no new safety signals with the perioperative nivolumab regimen and is consistent with the known safety profiles of individual agents. Grade 3-4 treatment-related side effects were observed in 32% and 25% of patients receiving the perioperative combination or control therapy, respectively. Surgery-related adverse events occurred in 12% of patients in both treatment arms.
These findings add to recent success seen with neoadjuvant nivolumab plus chemotherapy in NSCLC. In March 2022, the Phase III CheckMate 816 study led to FDA approval of nivolumab combined with platinum-based chemotherapy.
“I am enthusiastic about the initial findings of the study,” Cascone said. “Looking ahead, it will be critical to identify patient and disease characteristics that will tell us who can potentially be cured with neoadjuvant chemoimmunotherapy only and who will benefit from more intensified treatment strategies.”
The CheckMate 77T study was sponsored by Bristol Myers Squibb. A full list of co-authors and author disclosures can be found here.
Read the full release in the MD Anderson Newsroom.
END
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Phase III study finds perioperative nivolumab plus chemotherapy significantly lowers chance of disease recurrence, progression or death compared to chemotherapy alone
2024-05-15
ELSE PRESS RELEASES FROM THIS DATE:
'Trojan horse' weight loss drug more effective than available therapies
2024-05-15
“I consider the drugs available on the marked today as the first generation of weight-loss drugs. Now we have developed a new type of weight-loss drug that affects the plasticity of the brain and appears to be highly effective.”
So says Associate Professor and Group Leader Christoffer Clemmensen, from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, who is senior author of the new study, which has been published in the prestigious scientific journal Nature.
In the study, Christoffer Clemmensen and colleagues demonstrate a new use of the weight loss hormone GLP-1. GLP-1 can be used as a ‘Trojan ...
Reduced risk of breast cancer following bariatric surgery in women with hyperinsulinemia
2024-05-15
Bariatric surgery is associated with a reduced risk of breast cancer in women with obesity. These are the findings of a study conducted at the University of Gothenburg. The risk reduction is greatest for those with high blood insulin levels at the time of surgery.
The study, published in JAMA Surgery, is based on data from 2,867 women with obesity, half of whom had undergone bariatric surgery at 25 surgical departments. The remaining women, comprising the control group, received standard obesity treatment at 480 healthcare centers. The groups were otherwise comparable in terms of age and body composition.
The results show that a total of ...
Copper can't be mined fast enough to electrify the US
2024-05-15
Copper cannot be mined quickly enough to keep up with current U.S. policy guidelines to transition the country's electricity and vehicle infrastructure to renewable energy, according to a University of Michigan study.
The Inflation Reduction Act, signed into law in 2022, calls for 100% of cars manufactured to be electric vehicles by 2035. But an electric vehicle requires three to five times as much copper as an internal combustion engine vehicle—not to mention the copper required for upgrades to the electric grid.
"A ...
Guideline issued for people with epilepsy who may become pregnant
2024-05-15
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MAY 15, 2024
MINNEAPOLIS – A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology (AAN), and was developed through a collaboration between the AAN, the American Epilepsy Society (AES) and the Society for Maternal-Fetal Medicine (SMFM). It was endorsed by the Child Neurology Society.
The guideline partially updates two 2009 AAN and AES ...
Only 20% of U.S. nonprofit hospitals invested in housing as part of the federal community benefit mandate
2024-05-15
Waltham — May 15, 2024 — A nationwide assessment of how nonprofit hospitals are addressing housing-related needs in their communities appears in the latest issue of Medical Care, the official journal of the Medical Care Section of the American Public Health Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Approximately 60% of hospitals in the United States are 501(c)(3) nonprofit organizations ...
The crystallization of memory: Study reveals how practice forms new memory pathways in the brain
2024-05-15
A new study led by UCLA Health has shown that repetitive practice not only is helpful in improving skills but also leads to profound changes in the brain’s memory pathways.
The research, published in the journal Nature and co-led by Rockefeller University, sought to unravel how the brain’s ability to retain and process information, known as working memory, improves through training.
To test this, researchers tasked mice with identifying and recalling a sequence of odors over the course of two weeks. Researchers then tracked neural activity in the animals as they practiced the task by using a novel, custom-built microscope that can image cellular activity ...
Dartmouth-led study provides new insights into phage therapy design
2024-05-15
Results from a new Dartmouth-led study, involving collaborators at the University of Pittsburgh and Yale University and published in the journal PLOS Biology, are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF).
A major challenge of treating people with CF—an inherited disease that causes sticky, thick mucus to build up in the lungs—are the persistent infections the disease causes which can lead to respiratory failure and death.
“Opportunistic ...
This time, it’s personal: Enhancing patient response to cancer immunotherapy
2024-05-15
LA JOLLA (May 15, 2024)—Immunotherapy has revolutionized the way we treat cancer in recent years. Instead of targeting the tumor itself, immunotherapies work by directing patients’ immune systems to attack their tumors more effectively. This has been especially impactful in improving outcomes for certain difficult-to-treat cancers. Still, fewer than half of all cancer patients respond to current immunotherapies, creating an urgent need to identify biomarkers that can predict which patients are most likely to benefit.
Recently, scientists have noticed that patients whose tumors have a mutation in a gene called ARID1A are ...
A novel multifunctional catalyst turns methane into valuable hydrocarbons
2024-05-15
Methane, a greenhouse gas that contributes significantly towards global warming, is also an important source of energy and an essential chemical resource. When used as a chemical feedstock, methane is typically converted into methanol first and then into hydrocarbons. However, this sequential conversion requires complex industrial setups. More importantly, since methane is a very stable molecule, its conversion into methanol requires tremendous amounts of energy when using conventional means, such ...
Two decades of studies suggest health benefits associated with plant-based diets
2024-05-15
Vegetarian and vegan diets are generally associated with better status on various medical factors linked to cardiovascular health and cancer risk, as well as lower risk of cardiovascular diseases, cancer, and death, according to a new review of 49 previously published papers. Angelo Capodici and colleagues present these findings in the open-access journal PLOS ONE on May 15, 2024.
Prior studies have linked certain diets with increased risk of cardiovascular disease and cancer. A diet that is poor in plant products and rich in meat, refined grains, sugar, and salt is associated with higher risk of death. Reducing consumption of animal-based ...
LAST 30 PRESS RELEASES:
Nucleoporin93: A silent protector in vascular health
Can we avert the looming food crisis of climate change?
Alcohol use and antiobesity medication treatment
Study reveals cause of common cancer immunotherapy side effect
New era in amphibian biology
Harbor service, VAST Data provide boost for NCSA systems
New prognostic model enhances survival prediction in liver failure
China focuses on improving air quality via the coordinated control of fine particles and ozone
Machine learning reveals behaviors linked with early Alzheimer’s, points to new treatments
Novel gene therapy trial for sickle cell disease launches
Engineering hypoallergenic cats
Microwave-induced pyrolysis: A promising solution for recycling electric cables
Cooling with light: Exploring optical cooling in semiconductor quantum dots
Breakthrough in clean energy: Scientists pioneer novel heat-to-electricity conversion
Study finds opposing effects of short-term and continuous noise on western bluebird parental care
Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia
Sports betting and financial market data show how people misinterpret new information in predictable ways
Long COVID brain fog linked to lung function
Concussions slow brain activity of high school football players
Study details how cancer cells fend off starvation and death from chemotherapy
Transformation of UN SDGs only way forward for sustainable development
New study reveals genetic drivers of early onset type 2 diabetes in South Asians
Delay and pay: Tipping point costs quadruple after waiting
Magnetic tornado is stirring up the haze at Jupiter's poles
Cancers grow uniformly throughout their mass
Researchers show complex relationship between Arctic warming and Arctic dust
Brain test shows that crabs process pain
Social fish with low status are so stressed out it impacts their brains
Predicting the weather: New meteorology estimation method aids building efficiency
Inside the ‘swat team’ – how insects react to virtual reality gaming
[Press-News.org] Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancerPhase III study finds perioperative nivolumab plus chemotherapy significantly lowers chance of disease recurrence, progression or death compared to chemotherapy alone